Sign In
Buy GSK
$50.67
-1.48 (-2.84%)
At Close: Jun 18, 2026
GSK Q4 Earnings Call Highlights
01:36am, Friday, 06'th Feb 2026
GSK (NYSE: GSK) executives struck an upbeat tone on the company's full-year 2025 results call, pointing to broad-based sales growth, operating leverage, and a pipeline they said is gaining momentum. M
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of R
3 International Stocks to Buy for 2026
09:00am, Thursday, 05'th Feb 2026
Plus, which countries and sectors look most attractive to invest in today. In this bonus episode of The Morning Filter podcast, host Susan Dziubinski talks with Morningstar chief Europe markets strate
GSK plc (GSK) Q4 2025 Earnings Call Transcript
07:30pm, Wednesday, 04'th Feb 2026
GSK plc (GSK) Q4 2025 Earnings Call Transcript
GSK beat the numbers, but the real story was the guidance
10:32am, Wednesday, 04'th Feb 2026
A clean fourth-quarter beat pushed GSK ahead of its own medium-term targets. Yet management chose to set a deliberately modest bar for 2026, leaving investors to decide whether this is prudence or o
GSK beat the numbers, but the real story was the guidance
10:30am, Wednesday, 04'th Feb 2026
A clean fourth-quarter beat pushed GSK ahead of its own medium-term targets. Yet management chose to set a deliberately modest bar for 2026, leaving...
GSK's Q4 Earnings & Sales Beat Estimates, Stock Up on '26 Outlook
09:36am, Wednesday, 04'th Feb 2026
GSK's Q4 earnings and sales top estimates as strong specialty medicine demand fuels growth and drives shares higher on an upbeat 2026 outlook.
GSK (GSK) Surpasses Q4 Earnings and Revenue Estimates
08:06am, Wednesday, 04'th Feb 2026
GSK (GSK) came out with quarterly earnings of $0.68 per share, beating the Zacks Consensus Estimate of $0.64 per share. This compares to earnings of $0.59 per share a year ago.
GSK delivers solid 2025 results, reaffirms growth outlook for 2026
03:20am, Wednesday, 04'th Feb 2026
Specialty Medicines drive strong sales as company maintains guidance and raises dividend GSK PLC (LSE:GSK, NYSE:GSK) reported a 7% rise in sales for 2025 to £32.7 billion, led by strong performanc
GSK's Specialty Medicines Drive Solid Results
02:45am, Wednesday, 04'th Feb 2026
The pharma company posted double-digit percentage growth in its immunology and inflammation, oncology and HIV portfolios for 2025, with sales of £32.67 billion.
Why GSK (GSK) is a Top Value Stock for the Long-Term
10:40am, Tuesday, 03'rd Feb 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Wave Life Sciences Reclaims Rare Disease Drug From GSK, Targets Faster FDA Path
02:16pm, Monday, 02'nd Feb 2026
On Monday, Wave Life Sciences Ltd. (NASDAQ: WVE) said it regained full rights to WVE-006 from GSK Plc (NYSE: GSK).
AstraZeneca Moves to NYSE as $50 Billion US Investment Plan Takes Focus
12:29pm, Monday, 02'nd Feb 2026
AstraZeneca (AZN) is set to begin trading on the New York Stock Exchange on Monday, replacing its American Depositary Receipts that had been listed on Nasdaq, i
GSK (NYSE:GSK) Hits New 52-Week High – Time to Buy?
04:40am, Sunday, 01'st Feb 2026
GSK PLC Sponsored ADR (NYSE: GSK - Get Free Report) reached a new 52-week high during trading on Friday. The stock traded as high as $51.47 and last traded at $51.2950, with a volume of 2655250 shares
Top FTSE 100 Index shares to watch: BT Group, Vodafone, Shell, GSK
03:00am, Friday, 30'th Jan 2026
The FTSE 100 Index continued its rally this week and was hovering near its all-time high as market participants reacted to the key earnings by some American companies and Lloyds Bank. It was trading
